Jailani, Nancy B.

HRN: 27-22-29  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2025
CEFUROXIME 500MG (TAB)
05/31/2025
06/06/2025
PO
500mg
BID
Thickly MSAF
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: